Cardiac Pacemaker Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Cardiac Pacemaker Market Companies and it is Segmented by Type (Implantable (Single Chamber, Dual Chamber, and Biventricular) and External) and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market values are provided in terms of (USD million) for the above-mentioned segments.

Cardiac Pacemakers Market Size

Single User License


Team License


Corporate License


Book before:
Cardiac Pacemaker Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 4.68 Billion
Market Size (2029) USD 5.53 Billion
CAGR (2024 - 2029) 3.43 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Cardiac Pacemaker Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License


Team License


Corporate License


Book before:

Cardiac Pacemakers Market Analysis

The Global Cardiac Pacemakers Market size is estimated at USD 4.68 billion in 2024, and is expected to reach USD 5.53 billion by 2029, growing at a CAGR of 3.43% during the forecast period (2024-2029).

The COVID-19 pandemic slowed the growth of the cardiovascular market. Due to the high rate of infection and the lack of treatment, many countries are suffering and continue to carry a heavy burden on their economies and healthcare systems. Many countries had previously shut down and stopped trading with other countries due to travel restrictions, leading to a slowdown for large companies worldwide. The American College of Surgeons and the American Society of Anesthesiologists recommended a continuous reduction in the rate of new cases of COVID-19 14 days before the resumption of special surgery. Also, according to a research article published in Case Reports in Cardiology, 2020, temporary patients undergoing pacemaker transfusion are 2.5 times more likely to acquire COVID-19 infection before the first pacemaker (PPM) injection. Therefore, research suggested that the selection of temporary cardiac care providers increased the risk of long-term associated complications and transmission of infection to healthcare workers. Therefore, the market is expected to see negative growth due to the high risk associated with heart surgery during COVID-19.

The escalation of lifestyle-related disruptions, favorable reimbursement status, increased adult populations, and technological advances are expected to boost the market studied.

According to data from the World Population Prospects: Highlights 2020, approximately 1.5 billion people worldwide will be over 65 by 2050, up from 727 million by 2020. One in four people in Europe and North America will be 65 years or older by 2050. From 143 million in 2019 to 426 million by 2050, the number of people aged 80 and over is expected to triple. Pacing treatment is usually done to treat severe arrhythmia. According to a research article titled "Pacemaker Treatment for Older Patients: Survival and Specific Predicting Limits for One-Centered Experience", published in 2019, the number of older patients receiving pacemakers is growing, and European guidelines do not consider any age limits to installing a pacemaker.

In addition, according to a World Health Organization article published in July 2021, an estimated 17.9 million people worldwide die from heart disease every year, representing 31% of deaths globally, and 85% of these deaths are mainly caused by heart disease and stroke. Therefore, the growing burden of heart disease worldwide and technological advancements in the development of novel pacemakers are expected to boost the cardiovascular market during the forecast period.

Cardiac Pacemakers Market Trends

This section covers the major market trends shaping the Cardiac Pacemakers Market according to our research experts:

Implantable Cardiac Pacemakers Segment Captures the Largest Market Share and is Expected to Grow with a Lucrative Rate

The implanted cardiac pacemakers hold taken the largest market share. They are expected to register the most profitable growth rate during the forecast period. Installed pacemakers are of three main types, namely single chamber, dual-chamber, and biventricular pacemakers.

Reduced postoperative complications can cause partial growth. Biventricular pacemakers are expected to gain momentum due to the presence of multiple tracks. These devices can be installed in multiple locations as they consist of three tracks installed in the left and right atrium and the ventricle. These biventricular pacemakers are very useful due to their many benefits in helping with conditions such as ventricular dyssynchrony.

Additionally, growing technological advances and product approvals drive the segment's growth. For example, in July 2020, Abbott Laboratories received approval from the US Food and Drug Administration for its Gallant line, which includes an implanted cardioverter-defibrillator and a cardiac resynchronization therapy defibrillator with Bluetooth technology. Advanced features in pacemaker technology, such as remote data tracking devices, secure magnetic resonance imaging (MRI) devices, and data recording functionality, boost the segment's growth.

Therefore, implanted cardiac pacemakers are expected to show significant growth during the prognosis and boost the market.


North America Captured the Largest Market Share, and May Continue to Retain its Dominance During the Forecast Period

North America emerged as the largest regional market in terms of revenue. The high prevalence of cardiovascular disease, high obesity, and favorable revenues are key factors contributing to its huge market size.

According to the report titled "The number of older people will hit the US economy 'like a' brick '- US trade secretary", published in April 2021, about 16.5% of the US population, or 54 million, were over the age of 65 by 2020. By 2030, this number will rise to 74 million. The number of people over the age of 85 who are at risk of developing heart disease is expected to increase significantly. In addition, according to the American Heart Association's figures published in January 2019, nearly half of the American population has some form of heart disease, including high blood pressure. The spread of heart diseases creates a need for cardiovascular equipment, monitoring, and diagnostic equipment. Therefore, there is a great need for better treatment with advanced medical devices, which may drive the studied market.

In addition, the United States has become home to many key players, such as Abbott Laboratories and Boston Scientific Corporation, which play a key role in the development, construction, and marketing of cardiac suppliers. For example, in September 2019, EBR Systems Inc. acquired the US FDA Breakthrough Device Designation for WiSE (Wireless Stimulation Endocardially) CRT System to treat heart failure. Therefore, the increasing rate of heart diseases in the United States and the introduction of new products by key players are expected to boost the market during the forecast period.

Arrhythmia affects all age groups, but the risk of developing atrial fibrillation (AF) increases with age. As per Heart Disease and Stroke Statistics 2019, the risk of long-term atrial fibrillation is estimated to be 1 in 3 white people in the United States. In addition, the use of alcohol, tobacco, sedentary lifestyles, and certain over-the-counter drugs may increase the risk of arrhythmia.

Therefore, the North American cardiovascular market is expected to witness significant growth during the forecast period due to such factors.

Cardiac Pacemakers Market - Growth Rate by Region

Cardiac Pacemakers Industry Overview

The cardiac pacemakers market is moderately competitive and consists of a few dominant players, including Abbott Laboratories (ST. Jude Medical), Medtronic PLC, Boston Scientific Corporation, Biotronik SE & Co. KG, and Lepu Medical Co. Ltd.

Cardiac Pacemakers Market Leaders

  1. Medtronic PLC

  2. Biotronik SE & Co. KG

  3. Boston Scientific Corporation

  4. Lepu Medical Co . Ltd

  5. Abbott Laboratories (ST Jude Medical)

*Disclaimer: Major Players sorted in no particular order

Cardiac Pacemaker Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Cardiac Pacemakers Market News

  • In June 2021, India Medtronic Private Limited launched Micra AV, a miniaturized, fully self-contained pacemaker that delivers advanced pacing technology to atrioventricular (AV) block patients via a minimally invasive approach. The device is the first pacemaker that can sense atrial activity without a lead or device in the upper chamber of the heart
  • In January 2021, Boston Scientific Corporation announced its plan to acquire the remote cardiac monitoring developer, Preventice Solutions.

Cardiac Pacemakers Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Lifestyle-related Disorders

      2. 4.2.2 Rapidly Growing Geriatric Population

      3. 4.2.3 Advancements in Pacemaker Technology and Minimally Invasive Procedures

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs Associated with Application and Maintenance

      2. 4.3.2 Cyber Security Risk Associated with Connected Pacemakers

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Type

      1. 5.1.1 Implantable

        1. Single Chamber

        2. Dual Chamber

        3. Biventricular

      2. 5.1.2 External

    2. 5.2 By Geography

      1. 5.2.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.2.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories (ST Jude Medical)

      2. 6.1.2 Biotronik SE & Co. KG

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Lepu Medical Co. Ltd

      5. 6.1.5 Medico SpA

      6. 6.1.6 Medtronic PLC

      7. 6.1.7 Oscor Inc.

      8. 6.1.8 Osypca Medical GmbH

      9. 6.1.9 Zoll Medical Corporation

      10. 6.1.10 MicroPort Scientific Corporation

      11. 6.1.11 Cook Medical

      12. 6.1.12 Pacetronix

      13. 6.1.13 Sorin Group

    2. *List Not Exhaustive

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cardiac Pacemakers Industry Segmentation

As per the scope of the report, cardiac pacemakers are medical devices used to deliver electrical pulses to the heart to maintain a normal heart rate. Pacemakers are used to treat patients suffering from heart conditions, such as heart failure and arrhythmias. The cardiac pacemakers market is segmented by type and geography. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the above-mentioned segments.

By Type
Single Chamber
Dual Chamber
By Geography
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America
Need A Different Region Or Segment?
Customize Now

Cardiac Pacemakers Market Research FAQs

The Global Cardiac Pacemakers Market size is expected to reach USD 4.68 billion in 2024 and grow at a CAGR of 3.43% to reach USD 5.53 billion by 2029.

In 2024, the Global Cardiac Pacemakers Market size is expected to reach USD 4.68 billion.

Medtronic PLC, Biotronik SE & Co. KG, Boston Scientific Corporation, Lepu Medical Co . Ltd and Abbott Laboratories (ST Jude Medical) are the major companies operating in the Global Cardiac Pacemakers Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Global Cardiac Pacemakers Market.

In 2023, the Global Cardiac Pacemakers Market size was estimated at USD 4.52 billion. The report covers the Global Cardiac Pacemakers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Cardiac Pacemakers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Pacemaker Industry Report

Statistics for the 2024 Pacemaker market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Pacemaker analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Cardiac Pacemaker Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)